Placental growth factor levels neither reflect severity of portal hypertension nor portal-hypertensive gastropathy in patients with advanced chronic liver disease

被引:2
|
作者
Simbrunner, Benedikt [1 ,2 ,3 ]
Stadlmann, Alexander [1 ,2 ,4 ]
Schwabl, Philipp [1 ,2 ,3 ]
Paternostro, Rafael [1 ,2 ]
Bauer, David J. M. [1 ,2 ]
Bucsics, Theresa [1 ,2 ]
Scheiner, Bernhard [1 ,2 ]
Lampichler, Katharina [5 ]
Woeran, Katharina [6 ]
Beer, Andrea [6 ]
Eigenbauer, Ernst [7 ]
Pinter, Matthias [1 ]
Staettermayer, Albert-Friedrich [1 ]
Marculescu, Rodrig [8 ]
Szekeres, Thomas [8 ]
Trauner, Michael [1 ]
Mandorfer, Mattias [1 ,2 ,3 ]
Reiberger, Thomas [1 ,2 ,3 ]
机构
[1] Med Univ Vienna, Dept Internal Med 3, Div Gastroenterol & Hepatol, Vienna, Austria
[2] Med Univ Vienna, Vienna Hepat Hemodynam Lab, Vienna, Austria
[3] Med Univ Vienna, Christian Doppler Lab Portal Hypertens & Liver Fi, Vienna, Austria
[4] Hosp Hietzing, Vienna, Austria
[5] Med Univ Vienna, Dept Radiol, Vienna, Austria
[6] Med Univ Vienna, Dept Pathol, Vienna, Austria
[7] Med Univ Vienna, IT4Sci, Vienna, Austria
[8] Med Univ Vienna, Dept Lab Med, Vienna, Austria
关键词
Cirrhosis; HVPG; PLGF; SFLT1; Angiogenesis; Portal-hypertensive gastropathy;
D O I
10.1016/j.dld.2020.09.006
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background & Aims: Experimental data indicates that placental growth factor (PLGF) is involved in the pathophysiology of portal hypertension (PH) due to advanced chronic liver disease (ACLD). We investigated serum levels of PLGF and its "scavenger", the receptor soluble fms-like tyrosine kinase-1 (sFLT1, or sVEGFR1), in ACLD patients with different severity of PH and portal-hypertensive gastropathy (PHG). Methods: PLGF and sVEGFR1 were measured in ACLD patients with hepatic venous pressure gradient (HVPG) >= 6 mmHg (n = 241) and endoscopic evaluation of PHG (n = 216). Patients with pre-/posthepatic PH, TIPS, liver transplantation and hepatocellular carcinoma were excluded. Results: Thirty-two (13%) patients had HVPG 6-9 mmHg, 128 (53%) 10-19 mmHg and 81 (34%) 0.001) levels increased across HVPG strata, while PLGF/sVEGFR1 ratios remained similar (0.19 vs. 0.20 vs. 0.18 pg/mL; p = 0.140). The correlation between PLGF and HVPG was weak (Rho = 0.190,95%CI 0.06-0.31; p = 0.003), and the PLGF/sVEGFR1 ratio did not correlate with HVPG (p = 0.331). The area-under-the-receiver operating characteristics (AUROC) for PLGF to detect clinically significant PH (CSPH;i.e. HVPG 10 mmHg) yielded only 0.688 (0.60-0.78; p < 0.001). When compared to ACLD patients without PHG, PLGF levels (20 without vs. 21.4 with mild vs. 17.1 pg/mL with severe PHG, respectively; p = 0.005) and PLGF/sVEGFR1 ratios (0.20 vs. 0.19 vs. 0.17; p = 0.076) did not increase with mild and severe PHG. Conclusion: While PLGF levels tended to increase with severity of PH, the PLGF/sVEGFR1 ratio remained stable across HVPG strata. Neither PLGF nor the PLGF/sVEGFR1 ratio had diagnostic value for prediction of CSPH. The severity of PHG was also not associated with stepwise increases in PLGF levels or PLGF/sVEGFR1 ratio. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.
引用
收藏
页码:345 / 352
页数:8
相关论文
共 50 条
  • [31] Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study
    Zykus, Romanas
    Jonaitis, Laimas
    Petrenkiene, Vitalija
    Pranculis, Andrius
    Kupcinskas, Limas
    BMC GASTROENTEROLOGY, 2015, 15
  • [32] Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study
    Romanas Zykus
    Laimas Jonaitis
    Vitalija Petrenkienė
    Andrius Pranculis
    Limas Kupčinskas
    BMC Gastroenterology, 15
  • [33] Patients With Signs of Advanced Liver Disease and Clinically Significant Portal Hypertension Do Not Necessarily Have Cirrhosis
    Rodrigues, Susana G.
    Montani, Matteo
    Guixe-Muntet, Sergi
    De Gottardi, Andrea
    Berzigotti, Annalisa
    Bosch, Jaime
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (10) : 2101 - +
  • [34] Plasma interleukin-8 levels in patients with post-hepatitic cirrhosis: Relationship to severity of liver disease, portal hypertension and hyperdynamic circulation
    Li, CP
    Lee, FY
    Tsai, YT
    Lin, HC
    Lu, RH
    Hou, MC
    Wang, TF
    Chen, LS
    Wang, SS
    Lee, SD
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1996, 11 (07) : 635 - 640
  • [35] Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease
    Ankur Jindal
    Samagra Agarwal
    Sanchit Sharma
    Manoj Kumar
    Anoop Saraya
    Shiv Kumar Sarin
    Digestive Diseases and Sciences, 2023, 68 : 2149 - 2157
  • [36] Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease
    Jindal, Ankur
    Agarwal, Samagra
    Sharma, Sanchit
    Kumar, Manoj
    Saraya, Anoop
    Sarin, Shiv Kumar
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (05) : 2149 - 2157
  • [37] The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease
    Scheiner, Bernhard
    Northup, Patrick G.
    Gruber, Anselm B.
    Semmler, Georg
    Leitner, Gerda
    Quehenberger, Peter
    Thaler, Johannes
    Ay, Cihan
    Trauner, Michael
    Reiberger, Thomas
    Lisman, Ton
    Mandorfer, Mattias
    LIVER INTERNATIONAL, 2020, 40 (06) : 1415 - 1426
  • [38] Use of Noninvasive Markers of Portal Hypertension and Timing of Screening Endoscopy for Gastroesophageal Varices in Patients With Chronic Liver Disease
    Berzigotti, Annalisa
    Bosch, Jaime
    Boyer, Thomas D.
    HEPATOLOGY, 2014, 59 (02) : 729 - 731
  • [39] Clinical significance of substantially elevated von Willebrand factor antigen levels in patients with advanced chronic liver disease
    Pomej, Katharina
    Scheiner, Bernhard
    Balcar, Lorenz
    Nussbaumer, Rosa Johanna
    Weinzierl, Johanna
    Paternostro, Rafael
    Simbrunner, Benedikt
    Bauer, David
    Pereyra, David
    Starlinger, Patrick
    Staettermayer, Albert Friedrich
    Pinter, Matthias
    Trauner, Michael
    Quehenberger, Peter
    Reiberger, Thomas
    Mandorfer, Mattias
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (10) : 1376 - 1384
  • [40] DUPLEX DOPPLER ULTRASOUND OF THE LIGAMENTUM TERES AND PORTAL-VEIN - A CLINICALLY USEFUL ADJUNCT IN THE EVALUATION OF PATIENTS WITH KNOWN OR SUSPECTED CHRONIC LIVER-DISEASE OR PORTAL-HYPERTENSION
    GIBSON, PR
    GIBSON, RN
    DONLAN, JD
    DITCHFIELD, MR
    BHATHAL, PS
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1991, 6 (01) : 61 - 65